PT ORGANON PHARMA INDONESIA

PT ORGANON PHARMA INDONESIA is a Trading Company.

Company Introduction:

PT ORGANON PHARMA INDONESIA is the Indonesian subsidiary of Organon & Co., a global healthcare company dedicated to improving the health of women throughout their lives. Organon was established in June 2021 as a spin-off from Merck (known as MSD outside of the United States and Canada). The company focuses on addressing unmet health needs with a portfolio that spans women's health, biosimilars, and established trusted brands across various therapeutic areas. In Indonesia, PT ORGANON PHARMA INDONESIA is primarily responsible for the marketing, sales, and distribution of Organon's global pharmaceutical products, ensuring their availability and accessibility to patients and healthcare providers across the nation.

Here are some of the products that PT ORGANON PHARMA INDONESIA manufactures or markets:

* Contraceptives: Oral contraceptives, implants, and intrauterine devices (IUDs)

* Women's Health: Products for menopause management, osteoporosis, and reproductive health

* Dermatology: Skincare products

* Cardiovascular: Medications for heart conditions

* Pain Management: Pain relievers